Literature DB >> 22850968

Synthesis and antitumor activity of α-aminophosphonates containing thiazole[5,4-b]pyridine moiety.

Lijun Gu1, Cheng Jin.   

Abstract

A new procedure is developed for the synthesis of α-aminophosphonates containing thiazole[5,4-b]pyridine moiety from conveniently available starting materials. The target compounds were characterized by infrared, (1)H NMR, (13)C NMR, (31)P NMR, mass spectrometry and elemental analysis. The newly synthesized compounds were evaluated for their anticancer activities against PC-3, Bcap-37, H460 cells in vitro by the MTT method. Compounds 3b and 3f are highly effective against PC-3, Bcap-37 cells and good to H460 cells. Further study is necessary to find out the potential antitumor activities.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22850968     DOI: 10.1039/c2ob25875g

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  4 in total

Review 1.  Synthesis of Biologically Active Molecules through Multicomponent Reactions.

Authors:  Daniel Insuasty; Juan Castillo; Diana Becerra; Hugo Rojas; Rodrigo Abonia
Journal:  Molecules       Date:  2020-01-24       Impact factor: 4.411

2.  Cytotoxic Activity of Piperazin-2-One-Based Structures: Cyclic Imines, Lactams, Aminophosphonates, and Their Derivatives.

Authors:  Jakub Iwanejko; Mahzeiar Samadaei; Matthias Pinter; Daniel Senfter; Sibylle Madlener; Andrzej Kochel; Nataliya Rohr-Udilova; Elżbieta Wojaczyńska
Journal:  Materials (Basel)       Date:  2021-04-22       Impact factor: 3.623

3.  Low cytotoxicity and clastogenicity of some polymeric aminophosphonate derivatives.

Authors:  Anton Kril; Margarita Topashka-Ancheva; Any Georgieva; Ivan Iliev; Tsvetelina Gerasimova; Ivanka Kraicheva; Ivelina Tsacheva; Anita Bogomilova; Elitsa Vodenicharova; Kolio Troev
Journal:  Biotechnol Biotechnol Equip       Date:  2014-01-02       Impact factor: 1.632

4.  Theoretical exploration on structures, bonding aspects and molecular docking of α-aminophosphonate ligated copper complexes against SARS-CoV-2 proteases.

Authors:  Oval Yadav; Manjeet Kumar; Himanshi Mittal; Kiran Yadav; Veronique Seidel; Azaj Ansari
Journal:  Front Pharmacol       Date:  2022-10-03       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.